Healthcare Brief Comoros: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Brief Comoros.

Press releases published on October 28, 2026

9 hours ago

Benitec Biopharma Announces Positive Interim Phase 1b/2a Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 

Indeterminate GlobeNewswire

9 hours ago

Enlivex Announces Randomization of 135 Patients in Phase 2b Trial of Allocetra in Age-Related Primary Moderate-to-Severe Knee Osteoarthritis

Indeterminate GlobeNewswire

9 hours ago

Immutep Receives A$2.16 million French R&D Tax Incentive

Indeterminate GlobeNewswire

9 hours ago

Blue Lake Biotechnology Secures $5 Million Grant to Support Ongoing Pediatric Phase 1/2a Clinical Trial of Intranasal RSV Vaccine Candidate

Indeterminate GlobeNewswire

9 hours ago

PolyPid Unveils Expanded Pipeline Strategy, Introducing PD01B, a New Kynatrix™ Based Product Candidate for the Treatment of Diabetic Foot Infections

Indeterminate GlobeNewswire

9 hours ago

iTonic Holdings Ltd Regains Compliance with Nasdaq Minimum Bid Price Requirement

Indeterminate GlobeNewswire

9 hours ago

Global Diabetes Treatment and Innovation Market to Reach $295 Billion by 2031

Indeterminate GlobeNewswire

10 hours ago

Pyxis Oncology to Participate in Upcoming Investor Conferences

Indeterminate GlobeNewswire

10 hours ago

SIGA Secures Contract Valued at Up to $15 Million from Canadian Department of National Defence to Purchase TPOXX®

Indeterminate GlobeNewswire

10 hours ago

Palvella Announces FDA Acceptance and Priority Review of QTORIN™ Rapamycin NDA; February 28, 2027 PDUFA Target Action Date Set

Indeterminate GlobeNewswire

10 hours ago

Micron Biomedical Appoints Anand Subramony, Ph.D., as Executive Vice President, Global Product Development and Combination Product Commercialization

Indeterminate GlobeNewswire

10 hours ago

uniQure to Announce Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

10 hours ago

Mineralys Therapeutics Announces Publication of Phase 2 Explore-CKD Trial Results for Lorundrostat in Kidney International

Indeterminate GlobeNewswire

10 hours ago

Axogen, Inc. Reports Third Quarter 2026 Financial Results

Indeterminate GlobeNewswire

10 hours ago

Alvotech to Report Financial Results for the Nine-Month Period to September 30, 2026

Indeterminate GlobeNewswire

10 hours ago

Adagene Announces Dosing of First Patient in Phase 1 Study of Muzastotug in Combination with Incyte’s INCA33890 in Patients with Microsatellite Stable Colorectal Cancer

Indeterminate GlobeNewswire

10 hours ago

ADMA Biologics to Report Third Quarter 2026 Financial Results on November 4, 2026

Indeterminate GlobeNewswire

10 hours ago

Monte Rosa Therapeutics Announces Milestone Achievement Associated with Second Phase 2 Clinical Study Initiation for VAV1-directed Molecular Glue Degrader MRT-6160 (DDY391)

Indeterminate GlobeNewswire

10 hours ago

NovaBridge Biosciences Appoints Chuck Silberstein as Chief Financial Officer

Indeterminate GlobeNewswire

10 hours ago

Replimune Reports Fiscal Second Quarter 2027 Financial Results and Provides Corporate Update

Indeterminate GlobeNewswire